Cell and Gene Outsourcing

  1. Advancing Your Protein 5/5/2026

    Examine how a CMDO with extensive experience can deliver efficient and high-yielding custom protein manufacturing, supporting clients throughout the entire protein development process.

  2. Advancing CRISPR-Based Therapeutic Development 5/5/2026

    A CDMO that manufactures nucleases at research and cGMP grades can eliminate the need for custom manufacturing runs, simplify the transition to clinical application, and reduce regulatory paperwork.

  3. Advancing Innovations For mRNA Medicine Pioneers 5/5/2026

    Translating mRNA sequence to a high-quality drug product presents a complex challenge. Learn how partnering with a single contract manufacturer can alleviate potential delays and risks.

  4. Advancing Innovative Plasmid DNA Manufacturing Solutions For CGT 5/5/2026

    Supporting over 15 commercial therapy programs globally, we empower scientists with cutting-edge tools, personalized services, and regulatory support.

  5. Nucleic Acid-LNP Ultrafiltration And Diafiltration 5/5/2026

    Downstream filtration can make or break LNPs at scale. See how membrane format, loading, and shear affect recovery and stability — and how alternative TFF lowers scale‑up risk.

  6. Innovative Manufacturing Dedicated To The Cell And Gene Therapy Industry 5/5/2026

    Our commitment to continuous innovation enhances efficiency and safety, ensuring that patients can access these groundbreaking therapies sooner.

  7. Solving The DNA Knock-In Problem 5/1/2026

    An in‑depth exploration of why large, precise DNA knock‑ins limit cell therapy progress—and how site‑specific integration enables durable, scalable genetic engineering solutions.

  8. Expanding The Capabilities Of Targeted Integration 5/1/2026

    See the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.

  9. iPSC Drug Discovery Platform 5/1/2026

    An iPSC drug discovery platform delivering end‑to‑end genome engineering, differentiation, and GMP transition to generate biologically relevant human cell models for efficient discovery and translation.

  10. Bispecific T- Cell Engager (BiTE) Screening, Automated Pipeline 5/1/2026

    View automated, high‑throughput BiTE screening in mammalian cells, enabling rapid discovery of efficacious variants through precise genomic integration and scalable workflows.